Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Current Ratio

Co-Diagnostics, Inc. (CODX) Current Ratio

  • Current ratio · latest quarter: Value 1.81×; Formula and calculation Current assets / current liabilities..

Current ratio

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Current ratio · latest quarter1.81×Current assets / current liabilities.

$5.19M ÷ $2.86M ≈ 1.81×

Calculation inputs

InputAmount with unitRaw financial data
Current assets5.19M USDAssets, Current
Current obligations2.86M USDLiabilities, Current
Cash and equivalents3.65M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)Marketable Securities, Current
Customer receivables52.06K USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory841.67K USDInventory, Net
Payables1.08M USDAccounts Payable, Current
Borrowing debt due within one year(m)Long-term Debt, Current Maturities

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCurrent assets (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory (USD)Payables (USD)Borrowing debt due within one year (USD)Current ratio
2026-06-30$5.19M$2.86M$3.65M(m)$52.06K$841.67K$1.08M(m)1.81×
2026-03-31$9.78M$4.28M$8.23M(m)$82.34K$846.12K$2.02M(m)2.28×
2025-12-31$13.69M$3.54M$11.88M(m)$190.38K$992.40K$1.88M(m)3.87×
2025-09-30$14.05M$3.69M$11.44M(m)$55.91K$1.09M$1.46M(m)3.81×
2025-06-30$15.31M$3.71M$11.12M$2.25M$210.97K$1.08M$1.64M(m)4.12×
2025-03-31$23.83M$5.38M$1.90M$19.58M$136.39K$1.08M$2.71M(m)4.43×
2024-12-31$32.29M$7.32M$2.94M$26.81M$132.57K$1.07M$3.29M(m)4.41×
2024-09-30$40.10M$5.80M$10.80M$26.86M$178.24K$1.27M$2.18M(m)6.92×
2024-06-30$48.22M$5.31M$13.86M$31.02M$551.50K$1.46M$1.86M(m)9.09×
2024-03-31$53.70M$5.27M$23.10M$26.86M$434.87K$1.55M$2.03M(m)10.19×
2023-12-31$62.14M$5.75M$14.92M$43.63M$303.93K$1.66M$1.48M(m)10.81×
2023-09-30$71.31M$5.10M$10.24M$53.19M$806.70K$4.52M$1.42M(m)13.99×
2023-06-30$77.39M$5.12M$13.83M$55.31M$1.10M$4.69M$1.71M(m)15.13×
2023-03-31$85.92M$3.61M$6.36M$68.92M$2.70M$5.29M$829.82K(m)23.80×
2022-12-31$92.73M$3.87M$22.97M$58.29M$3.45M$5.31M$952.30K(m)23.94×
2022-09-30$101.92M$6.01M$81.51M$4.98M$7.96M$5.44M$2.06M(m)16.95×
2022-06-30$114.57M$6.72M$86.05M$9.95M$12.26M$4.71M$848.38K(m)17.06×
2022-03-31$125.34M$13.02M$97.42M(m)$21.66M$4.90M$1.22M(m)9.63×
2021-12-31$115.12M$12.60M$88.61M$1.26M$20.84M$2.00M$607.51K(m)9.14×
2021-09-30$102.29M$4.12M$82.66M$1.25M$14.59M$3.30M$800.00K(m)24.83×
2021-06-30$90.32M$4.73M$70.27M$2.11M$12.76M$4.12M$427.14K(m)19.10×
2021-03-31$79.13M$4.31M$57.79M$2.30M$12.12M$6.20M$667.59K(m)18.37×
2020-12-31$67.81M$4.06M$42.98M$4.34M$12.14M$8.00M$598.32K(m)16.69×
2020-09-30$51.95M$1.81M$21.23M$6.05M$10.64M$10.73M$250.47K(m)28.63×
2020-06-30$36.90M$2.98M$18.55M(m)$5.35M$10.11M$1.13M(m)12.36×
2020-03-31$19.61M$1.19M$17.37M(m)$1.06M$686.08K$132.52K(m)16.43×
2019-12-31$1.58M$328.07K$893.14K(m)$131.38K$197.17K$5.96K(m)4.83×
2019-09-30$3.08M$307.88K$2.54M(m)$60.35K$17.35K$21.76K(m)10.02×
2019-06-30$4.56M$312.08K$3.86M(m)$62.98K$8.23K$35.90K(m)14.61×
2019-03-31$5.58M$337.51K$5.41M(m)$42.56K$18.15K$96.31K(m)16.52×
2018-12-31$1.05M$2.35M$950.24K(m)$13.42K$18.15K$148.97K$1.91M0.45×
2018-09-30$2.39M$2.19M$2.18M(m)(m)(m)$66.67K(m)1.09×
2018-06-30$1.78M$290.57K$1.53M(m)(m)(m)$33.30K(m)6.13×
2018-03-31$3.14M$286.34K$2.54M(m)(m)(m)$35.74K(m)10.98×
2017-12-31$4.45M$628.26K$3.53M(m)(m)$9.07K$40.82K(m)7.09×
2017-09-30$5.91M$677.02K$4.63M(m)(m)$45.34K$80.50K(m)8.73×
2017-06-30$313.36K$4.67M$116.77K(m)(m)(m)$115.55K$2.64M0.07×
2016-12-31$1.21M$3.85M$998.74K(m)(m)(m)$29.93K$2.56M0.31×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01